Lindbrook Capital, LLC - TRACON PHARMACEUTICALS INC ownership

TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 36 filers reported holding TRACON PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of TRACON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$8,000
-57.9%
2,000
-33.3%
0.00%
-50.0%
Q2 2021$19,000
-64.2%
3,000
-53.8%
0.00%
-66.7%
Q1 2021$53,000
+1.9%
6,500
-35.0%
0.01%
-14.3%
Q3 2020$52,00010,0000.01%
Other shareholders
TRACON PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Opaleye Management Inc. 4,764,508$9,004,9202.70%
Ikarian Capital, LLC 2,765,530$5,226,8511.19%
JOHNSON & JOHNSON 84,003$158,7660.05%
X-Square Capital, LLC 17,743$340.02%
BOOTHBAY FUND MANAGEMENT, LLC 258,844$489,2150.01%
LINDEN ADVISORS LP 454,916$859,7910.01%
HoyleCohen, LLC 13,000$24,5700.00%
MGO ONE SEVEN LLC 11,780$22,2640.00%
Bank of New York Mellon Corp 66,606$125,8850.00%
Citadel Advisors 24,700$46,6830.00%
View complete list of TRACON PHARMACEUTICALS INC shareholders